MetaStat Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 6

Employees

  • Stock Symbol
  • MTST

Stock Symbol

MetaStat General Information

Description

MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.

Contact Information

Formerly Known As
Photovoltaic Solar Cells, Photovoltaic Solar Cells, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 27 Drydock Avenue
  • 2nd Floor
  • Boston, MA 02210
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 27 Drydock Avenue
  • 2nd Floor
  • Boston, MA 02210
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MetaStat Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
2.26K

MetaStat Financials Summary

As of 28-Feb-2018, MetaStat has a trailing 12-month revenue of $23.3K.

In Thousands,
USD
TTM 28-Feb-2018 FY 2018 28-Feb-2018 FY 2017 28-Feb-2017 FY 2016 29-Feb-2016
EV 7,201 7,201 6,039 4,144
Revenue 23 23 0 0
EBITDA (2,973) (2,973) (1,783) (4,241)
Net Income (3,181) (3,181) (2,942) (4,654)
Total Assets 730 730 1,262 1,063
Total Debt 1,000 1,000 989 1,533
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MetaStat Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MetaStat‘s full profile, request access.

Request a free trial

MetaStat Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (R
Biotechnology
Boston, MA
6 As of 2018

San Diego, CA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MetaStat Competitors (4)

One of MetaStat’s 4 competitors is Cardiff Oncology, a Formerly Angel backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardiff Oncology Formerly Angel backed San Diego, CA
Fore Biotherapeutics Venture Capital-Backed Philadelphia, PA
Genentech Formerly VC-backed South San Francisco, CA
Myriad Genetics Corporation Salt Lake City, UT
To view MetaStat’s complete competitors history, request access »

MetaStat Patents

MetaStat Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022140789-A Methods and compositions for anti-cancer therapy targeting mena protein isoform kinase Pending 08-Jul-2016
CA-3029999-A1 Methods and compositions for anticancer therapies that target mena protein isoforms kinases Pending 08-Jul-2016
EP-3481423-A1 Methods and compositions for anticancer therapies that target mena protein isoforms kinases Inactive 08-Jul-2016
EP-3481423-A4 Methods and compositions for anticancer therapies that target mena protein isoforms kinases Inactive 08-Jul-2016
US-20190225707-A1 Methods and compositions for anticancer therapies that target mena protein isoforms kinases Active 08-Jul-2016 C07K16/40
To view MetaStat’s complete patent history, request access »

MetaStat Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MetaStat ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Electrical Equipment

Industry

Rank

Percentile

Electrical Equipment

Subindustry

Rank

Percentile

To view MetaStat’s complete esg history, request access »

MetaStat FAQs

  • When was MetaStat founded?

    MetaStat was founded in 2007.

  • Where is MetaStat headquartered?

    MetaStat is headquartered in Boston, MA.

  • What is the size of MetaStat?

    MetaStat has 6 total employees.

  • What industry is MetaStat in?

    MetaStat’s primary industry is Biotechnology.

  • Is MetaStat a private or public company?

    MetaStat is a Public company.

  • What is MetaStat’s stock symbol?

    The ticker symbol for MetaStat is MTST.

  • What is MetaStat’s current revenue?

    The trailing twelve month revenue for MetaStat is $23.3K.

  • Who are MetaStat’s competitors?

    Cardiff Oncology, Fore Biotherapeutics, Genentech, and Myriad Genetics are competitors of MetaStat.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process